(ISSN 2573-4407)
OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 7.5 weeks; Submission to Acceptance: 15.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)
Special Issue
Multi-modal Neuroimaging Integration
Submission Deadline: May 31, 2025 (Open) Submit Now
Guest Editor
Yongxia Zhou, PhD
Department of Radiology, University of Southern California, USA
Research Interests: Traumatic Brain Injury; EEG; Autism; Neuroimaging; Functional neuroimaging; Brain connectivity; Cognitive neuroscience; Memory; Brain injury; Brain; Neuroplasticity; Neurodevelopment; Neuropsychiatry; Integrative imaging; Arts and Science
About This Topic
Integrative imaging with multi-modalities such as simultaneous PET/MRI had been utilized widely to study complex human functions for monitoring multiple biological signals at various conditions including task processing or in response to pharmacological interventions with high spatiotemporal resolution. In neurodegenerative diseases such as Alzheimer’s disease (AD), PET/MRI also provided better diagnosis accuracy with advanced dual imaging quantifications and intrinsic co-registration of two imaging modalities. Other clinical applications had been reported with combined PET and MRI molecular, structural and functional imaging features in the areas of quantitative therapeutic assessments and early disease prevention for cancer patients. More accurate quantification, synchronous pathophysiology investigation and consistent cross-validation could be achieved with advanced PET/MRI imaging techniques, including fast reconstruction with improved attenuation correction for better integration and expected correlation with other biomarkers (e.g., multiomics). The purpose of this special issue is to introduce instrumentation innovations of combined imaging equipments, new methodological developments as well as to demonstrate scientific and clinical applications of these techniques. The potential topics include multi-parametric imaging at molecular, metabolic, functional, structural, micro-structural and brain circuits levels, comprehensive imaging evidence and disease interpretation, application and generalization to large clinical data cohort.
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (neurobiology@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
TOP